Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.
Dantal, Jacques
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 09 2018 - 2612-2620 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
1527-7755
10.1200/JCO.2017.76.6691 doi
Calcineurin Inhibitors--adverse effects
Carcinoma, Squamous Cell--immunology
Humans
Immunocompromised Host--drug effects
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Secondary Prevention--methods
Sirolimus--therapeutic use
Skin Neoplasms--immunology
Transplant Recipients
Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 09 2018 - 2612-2620 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
1527-7755
10.1200/JCO.2017.76.6691 doi
Calcineurin Inhibitors--adverse effects
Carcinoma, Squamous Cell--immunology
Humans
Immunocompromised Host--drug effects
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Secondary Prevention--methods
Sirolimus--therapeutic use
Skin Neoplasms--immunology
Transplant Recipients